
    
      Patient is treated with LEAF-4L6715, a liposomal transcrocetin. The liposomal formulation
      allows for a gradual release of the free drug, thereby facilitating less frequent dosing.

      Pharmacokinetic assessment will be carried out to identify an optimal dose and schedule.
    
  